https://www.expansion.com/economia/financial-times/2026/10/30/podra-belen-garijo-revitalizar-cartera-productos-desarrollo-sanofi.html
Belén Garijo faces pressure to develop new successful drugs for Sanofi to replace Dupixent revenue. Sanofi's product pipeline is under review. Dupixent remains a key revenue source.
Image:
Image:
#sanofi #pharmaceuticals #dupixent
Belén Garijo faces pressure to develop new successful drugs for Sanofi to replace Dupixent revenue. Sanofi's product pipeline is under review. Dupixent remains a key revenue source.
Image:
Image:
#sanofi #pharmaceuticals #dupixent
Views: 11
Categories: News & Updates [c3]